Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.

Du J, Widlund HR, Horstmann MA, Ramaswamy S, Ross K, Huber WE, Nishimura EK, Golub TR, Fisher DE.

Cancer Cell. 2004 Dec;6(6):565-76.

2.

Expression of gp100 and CDK2 in melanoma cells is not co-regulated by a shared promoter region.

Stennett LS, Riker AI, Kroll TM, ChaMberlin J, Miki T, Nickoloff BJ, Le Poole IC.

Pigment Cell Res. 2004 Oct;17(5):525-32.

PMID:
15357840
3.

MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.

Du J, Miller AJ, Widlund HR, Horstmann MA, Ramaswamy S, Fisher DE.

Am J Pathol. 2003 Jul;163(1):333-43.

4.

Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability.

McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK, Lin YL, Ramaswamy S, Avery W, Ding HF, Jordan SA, Jackson IJ, Korsmeyer SJ, Golub TR, Fisher DE.

Cell. 2002 Jun 14;109(6):707-18.

5.

MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.

Ondrušová L, Vachtenheim J, Réda J, Záková P, Benková K.

PLoS One. 2013;8(1):e54110. doi: 10.1371/journal.pone.0054110. Epub 2013 Jan 17.

7.
8.

No evidence of a role for activating CDK2 mutations in melanoma.

Walker G, Hayward N.

Melanoma Res. 2001 Aug;11(4):343-8.

PMID:
11479422
9.

BPTF transduces MITF-driven prosurvival signals in melanoma cells.

Dar AA, Majid S, Bezrookove V, Phan B, Ursu S, Nosrati M, De Semir D, Sagebiel RW, Miller JR 3rd, Debs R, Cleaver JE, Kashani-Sabet M.

Proc Natl Acad Sci U S A. 2016 May 31;113(22):6254-8. doi: 10.1073/pnas.1606027113. Epub 2016 May 16.

10.
11.

Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.

Buscà R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B, Thyss R, Fitsialos G, Larribère L, Bertolotto C, Virolle T, Barbry P, Pouysségur J, Ponzio G, Ballotti R.

J Cell Biol. 2005 Jul 4;170(1):49-59. Epub 2005 Jun 27.

12.

Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.

Keenen B, Qi H, Saladi SV, Yeung M, de la Serna IL.

Oncogene. 2010 Jan 7;29(1):81-92. doi: 10.1038/onc.2009.304. Epub 2009 Sep 28.

13.

Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.

Fang D, Setaluri V.

Biochem Biophys Res Commun. 1999 Mar 24;256(3):657-63.

PMID:
10080955
14.

Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.

Wellbrock C, Rana S, Paterson H, Pickersgill H, Brummelkamp T, Marais R.

PLoS One. 2008 Jul 16;3(7):e2734. doi: 10.1371/journal.pone.0002734.

15.

Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma.

Jalili A, Wagner C, Pashenkov M, Pathria G, Mertz KD, Widlund HR, Lupien M, Brunet JP, Golub TR, Stingl G, Fisher DE, Ramaswamy S, Wagner SN.

J Natl Cancer Inst. 2012 Nov 7;104(21):1673-9. doi: 10.1093/jnci/djs373. Epub 2012 Sep 20.

16.
17.

Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma.

Miller AJ, Du J, Rowan S, Hershey CL, Widlund HR, Fisher DE.

Cancer Res. 2004 Jan 15;64(2):509-16.

18.

Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.

Vachtenheim J, Novotná H.

Cell Mol Biol (Noisy-le-grand). 1999 Nov;45(7):1075-82.

PMID:
10644012
19.
20.

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.

Nature. 2005 Jul 7;436(7047):117-22.

Supplemental Content

Support Center